The candidate NRGs were all highly expressed in thyroid cancer tissues, and candidate neoantigen genes, such as CDH6, ODZ1, and PROS1, were significantly differentially expressed in thyroid cancers. The gene discussed is CDH6; the disease is thyroid cancer.